Treating Benign Prostatic Hyperplasia (BPH): Recommendations and Guidelines Discussion by Dr. Hadley

2 Views
Published
David A. Hadley, MD, urologist at Kettering Health in Kettering, Ohio, focuses on diagnosing and treating benign prostatic hyperplasia (BPH), emphasizing office evaluation, diagnostic limitations, and non-surgical management strategies. In this 9-minute presentation, Hadley discusses the inadequacies of current diagnostic tools, noting that the complexity of diagnosing BPH underscores the need for a hybrid approach. He advocates for a validated bladder diary for more accurate patient assessment.

The presentation then examines the AUA guidelines for medical therapy, noting the increasing role of daily tadalafil or tamsulosin as a first-line treatment for BPH. Dr. Hadley also highlights the correlation between PSA levels and prostate size as critical factors in determining appropriate treatment strategies. A panel of other urology experts chimes in on the discussion, led by Dr. Hadley as well.
Category
Urology
Be the first to comment